Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • eperisone hydrochloride cas 56839-43-1

Oct . 31, 2024 08:11 Back to list

eperisone hydrochloride cas 56839-43-1



Eperisone Hydrochloride A Comprehensive Overview


Eperisone hydrochloride, identified by its CAS number 56839-43-1, is a skeletal muscle relaxant that exerts its therapeutic effects primarily through the central nervous system. It is particularly indicated for the treatment of muscle spasticity and pain associated with various musculoskeletal conditions. The following article delves into the pharmacological properties, therapeutic applications, and safety profile of eperisone hydrochloride.


Eperisone Hydrochloride A Comprehensive Overview

Eperisone hydrochloride is primarily employed in the treatment of conditions such as lumbar disc herniation, cervical spondylosis, and muscular pain following injury or surgery. Its effectiveness has gained acceptance among healthcare practitioners, particularly in the fields of orthopedics and rehabilitation. The drug is often prescribed in conjunction with physical therapy to enhance overall treatment efficacy, as it allows patients to participate more actively in rehabilitation exercises without the hindrance of painful muscle spasms.


eperisone hydrochloride cas 56839-43-1

eperisone hydrochloride cas 56839-43-1

One advantage of eperisone hydrochloride over some traditional muscle relaxants is its favorable safety profile. Clinical studies have demonstrated that it is generally well-tolerated, with lower reports of adverse events such as sedation, dizziness, and dependency, which are more common with benzodiazepines or other narcotic muscle relaxants. However, as with any medication, patients should be monitored for potential side effects, including gastrointestinal disturbances or skin reactions.


In terms of dosage, eperisone hydrochloride is typically administered orally, with the usual adult dose ranging from 50 to 100 mg taken three times a day. Adjustments may be necessary based on individual patient response and tolerability. It is crucial for patients to adhere to prescribed dosages and schedule to achieve optimal therapeutic outcomes while minimizing risks.


In conclusion, eperisone hydrochloride (CAS 56839-43-1) represents a significant advancement in the management of muscle spasticity and pain, offering a unique profile that combines muscle relaxation with enhanced blood circulation. Its safety and efficacy in various clinical applications make it a valuable asset in modern therapeutic regimens. As research continues to unfold, the potential for eperisone in treating other conditions beyond musculoskeletal disorders remains an exciting avenue for future exploration. As always, medical guidance should be sought to navigate the complexities of treatment options tailored to an individual’s healthcare needs.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish